Astera Labs (NASDAQ:ALAB) Trading 3.6% Higher – Still a Buy?

Astera Labs, Inc. (NASDAQ:ALAB)’s share price traded up 3.6% on Thursday . The company traded as high as $298.36 and last traded at $297.84. 6,987,332 shares changed hands during mid-day trading, an increase of 27% from the average session volume of 5,511,462 shares. The stock had previously closed at $287.48.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs has benefited from fresh bullish commentary and analyst upgrades, helping reinforce the view that its connectivity chips are a key AI infrastructure play. Article Title
• Positive Sentiment: Traders also pointed to strong order-flow and options activity, including elevated call volume and a Power Inflow signal, which can add short-term upside pressure to a fast-rising stock. Article Title
• Positive Sentiment: Recent market coverage highlighted Astera Labs’ strong earnings and revenue growth, along with optimism around new switch and optical networking opportunities tied to AI data centers. Article Title
• Neutral Sentiment: Astera Labs’ general counsel sold shares to cover tax withholding obligations from vesting equity awards, which is a routine transaction but still adds to recent insider-selling headlines. Article Title
• Negative Sentiment: Multiple executives, including the CEO, COO, and general counsel, sold shares in recent filings; while some sales were under pre-arranged plans or for taxes, the cluster of insider selling can temper enthusiasm near recent highs. Article Title

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Citigroup raised their price target on shares of Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Barclays raised their target price on Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. TD Cowen raised their target price on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research report on Wednesday, May 6th. UBS Group began coverage on Astera Labs in a research report on Tuesday, April 21st. They issued a “neutral” rating and a $180.00 target price on the stock. Finally, Evercore restated an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research report on Tuesday. Fifteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Price Performance

The company’s 50 day moving average price is $163.12 and its two-hundred day moving average price is $157.97. The stock has a market capitalization of $51.05 billion, a PE ratio of 201.24, a P/E/G ratio of 3.23 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period last year, the firm posted $0.33 earnings per share. The company’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Insiders Place Their Bets

In related news, COO Sanjay Gajendra sold 230,639 shares of Astera Labs stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $198.22, for a total transaction of $45,717,262.58. Following the transaction, the chief operating officer owned 664,361 shares in the company, valued at approximately $131,689,637.42. This trade represents a 25.77% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares in the company, valued at approximately $34,420,457.43. The trade was a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 1,635,461 shares of company stock valued at $288,735,776 in the last ninety days. 12.50% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Royal Bank of Canada raised its stake in Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the period. AQR Capital Management LLC raised its stake in Astera Labs by 213.4% during the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares during the period. Empowered Funds LLC raised its position in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock valued at $277,000 after buying an additional 4,183 shares during the period. First Trust Advisors LP raised its position in shares of Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock valued at $10,196,000 after buying an additional 56,952 shares during the period. Finally, Brown Advisory Inc. raised its position in shares of Astera Labs by 54.9% during the 2nd quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after buying an additional 1,977 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.